US stock market predictions and analysis from a team of experienced analysts dedicated to helping you achieve financial success. We combine fundamental analysis, technical indicators, and market sentiment to provide comprehensive stock evaluations.
As of 2026-04-09, Replimune Group Inc. (REPL) is trading at $6.16, posting a 4.59% gain on the session amid mixed broader market activity. This analysis, aligned with recent market coverage of REPL, explores key technical levels, recent trading context, and potential near-term scenarios for the clinical-stage biotechnology firm, which focuses on developing oncolytic immunotherapies for cancer treatment. No recent earnings data is available for REPL at the time of writing, so short-term price act
Is Replimune Group (REPL) Stock cyclical or stable | Price at $6.16, Up 4.59% - Social Investment Platform
REPL - Stock Analysis
4179 Comments
1197 Likes
1
Kartrina
Consistent User
2 hours ago
Short-term corrections may offer better risk-reward opportunities.
👍 252
Reply
2
Jazya
Expert Member
5 hours ago
I don’t know why but this has main character energy.
👍 122
Reply
3
Yeji
Returning User
1 day ago
This would’ve helped me make a better decision.
👍 74
Reply
4
Zarhiya
New Visitor
1 day ago
Expert US stock portfolio construction guidance with risk-adjusted return optimization for long-term wealth building. We help you build a diversified portfolio that can weather market volatility while capturing upside potential.
👍 226
Reply
5
Vere
Senior Contributor
2 days ago
I understand the words, not the meaning.
👍 46
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.